ACTIVE SUBSTANCE / INN

TAFAMIDIS MEGLUMINE

Brand name(s): VYNDAQEL
FDA LISTED
DISCONTINUED
NDA211996
ACTIVE SUBSTANCE
Tafamidis Meglumine
REGULATORS
FDA
SPONSORS / MAH
FOLDRX PHARMS
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VYNDAQELNDA211996FOLDRX PHARMSDiscontinued

FULL INTELLIGENCE ON TAFAMIDIS MEGLUMINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →